scholarly journals Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication

2009 ◽  
Vol 19 (3) ◽  
pp. 275-279 ◽  
Author(s):  
Lauren Shin ◽  
Hallie Bregman ◽  
Janis L. Breeze ◽  
Nancy Noyes ◽  
Jean A. Frazier
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Weight Control ◽  
Pediatric Patients ◽  
Atypical Antipsychotic Medication

Atypical Antipsychotic Weight Gain: A Major Clinical Challenge

2003 ◽  
Vol 37 (6) ◽  
pp. 705-709 ◽  
Author(s):  
Jenny-Kay Sharpe ◽  
Andrew P. Hills
Keyword(s):  
Physical Activity ◽  
Weight Gain ◽  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Weight Control ◽  
Psychotic Disorders ◽  
Lifestyle Changes ◽  
Future Research ◽  
Control Group ◽  
Atypical Antipsychotic Medication

Objective: The major aim of this paper is to review findings from weight management intervention studies to consider clozapine and/or olanzapine induced weight gain. A parallel aim is to summarize the challenges facing future research and provide an overview of best practice in the management of weight in mental health patients. Method: A systematic literature search was conducted using Medline, Cinahl and PsychINFO data bases and reference lists from relevant published articles. Five studies which reported weight control practices in patients taking atypical antipsychotic medications were located and reviewed. Results: The studies reviewed provide some important descriptive clinical insights; however, common shortcomings include small subject numbers and methodological drawbacks such as lack of a control group. Conclusions: There is some evidence that weight gain associated with atypical antipsychotic medication can be ameliorated by lifestyle changes such as improved nutritional practices and increased physical activity. Lifestyle interventions for individuals with psychotic disorders may need to be adapted to be most effective; for example, using strategies to counter increased appetite and to enhance physical activity. Clinicians need to be vigilant and persistent in monitoring and intervening if weight gain occurs. A standardized screening tool and clinical pathway would help clinicians to target appropriate interventions for each person prescribed atypical antipsychotic medication.

THE REVISED DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA: EVIDENCE FROM PHARMACOLOGICAL MRI STUDIES WITH ATYPICAL ANTIPSYCHOTIC MEDICATION

2008 ◽  
Vol 102 (1-3) ◽  
pp. 96-97 ◽  
Author(s):  
Fabiana da Silva Alves ◽  
Martijn Figee ◽  
Therese van Amelsvoort ◽  
Dick Veltman ◽  
Lieuwe de Haan
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Mri Studies ◽  
Dopamine Hypothesis ◽  
Pharmacological Mri ◽  
Atypical Antipsychotic Medication

scholarly journals Atypical antipsychotic medication poisoning: An evidence-based consensus guideline for out-of-hospital management

2007 ◽  
Vol 45 (8) ◽  
pp. 918-942 ◽  
Author(s):  
Daniel J. Cobaugh ◽  
Andrew R. Erdman ◽  
Lisa L. Booze ◽  
Elizabeth J. Scharman ◽  
Gwenn Christianson ◽  
...  
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Hospital Management ◽  
Evidence Based ◽  
Consensus Guideline ◽  
Atypical Antipsychotic Medication

scholarly journals Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia

2005 ◽  
Vol 62 (9) ◽  
pp. 961 ◽  
Author(s):  
Scott W. Woods ◽  
Ralitza V. Gueorguieva ◽  
C. Bruce Baker ◽  
Robert W. Makuch
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Control Group ◽  
Atypical Antipsychotic Medication
Sign in / Sign up

Export Citation Format

Share Document